BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.
Bio shares rose sharply after announcing upcoming presentations on its obesity treatment candidate at two industry ...
13h
BioNTech (BNTX): Assessing Valuation as Investor Sentiment Shifts After Recent Pipeline Developments
BioNTech (BNTX) shares have been on a bit of a ride recently, with the latest movement sparking conversations among those watching the biotech space. Investors are weighing the stock’s performance ...
Investor's Business Daily on MSN
Biotech Leader Travere Therapeutics Eyes Buy Point After More Than Doubling
Thursday's IBD 50 Growth Stocks To Watch pick, biotech leader Travere Therapeutics TVTX, is approaching its latest buy point ...
Zacks Investment Research on MSN
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
Amgen (AMGN) ended the recent trading session at $292.89, demonstrating a -1.04% change from the preceding day's closing price. This change lagged the S&P 500's 0.58% gain on the day. Meanwhile, the ...
Hyperliquid Strategies, a crypto treasury entity focused on the Hyperliquid, has filed papers to raise up to $1 billion to ...
After entering into a definitive agreement to acquire CureVac—who focuses on mRNA-based medicines for oncology and infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback